PALOMAR MEDICAL TECHNOLOGIES INC (PMTI) financial statements (2021 and earlier)
Company profile
| Business Address |
15 NETWORK DRIVE BURLINGTON, MA 01803 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2012 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | 88 | ||
| Cash and cash equivalents | 55 | ||
| Short-term investments | 33 | ||
| Receivables | 11 | ||
| Inventory, net of allowances, customer advances and progress billings | 22 | ||
| Inventory | 22 | ||
| Prepaid expense and other current assets | 1 | ||
| Total current assets: | 121 | ||
| Noncurrent Assets | |||
| Property, plant and equipment | 36 | ||
| Long-term investments and receivables | 12 | ||
| Long-term investments | 12 | ||
| Prepaid expense and other noncurrent assets | 0 | ||
| Total noncurrent assets: | 48 | ||
| TOTAL ASSETS: | 169 | ||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 11 | ||
| Accounts payable | 2 | ||
| Accrued liabilities | 9 | ||
| Taxes payable | 1 | ||
| Deferred revenue and credits | 3 | ||
| Other undisclosed current liabilities | (1) | ||
| Total current liabilities: | 14 | ||
| Noncurrent Liabilities | |||
| Liabilities, other than long-term debt | 4 | ||
| Deferred revenue and credits | 1 | ||
| Accrued income taxes | 3 | ||
| Total noncurrent liabilities: | 4 | ||
| Total liabilities: | 18 | ||
| Stockholders' equity | |||
| Stockholders' equity attributable to parent | 151 | ||
| Common stock | 0 | ||
| Treasury stock, value | (0) | ||
| Additional paid in capital | 221 | ||
| Accumulated other comprehensive loss | (0) | ||
| Accumulated deficit | (71) | ||
| Total stockholders' equity: | 151 | ||
| TOTAL LIABILITIES AND EQUITY: | 169 | ||
Income statement (P&L) ($ in millions)
| 12/31/2012 | ||
|---|---|---|
| Revenues | 81 | |
| Revenue, net | 21 | |
| Cost of revenue | (38) | |
| Cost of goods and services sold | (11) | |
| Gross profit: | 43 | |
| Operating expenses | (49) | |
| Operating loss: | (6) | |
| Nonoperating expense (Other Nonoperating expense) | (0) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | |
| Loss from continuing operations before income taxes: | (6) | |
| Income tax expense | (0) | |
| Net loss available to common stockholders, diluted: | (6) | |
Comprehensive Income ($ in millions)
| 12/31/2012 | ||
|---|---|---|
| Net loss: | (6) | |
| Other comprehensive income | 0 | |
| Comprehensive loss, net of tax, attributable to parent: | (6) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.